Dr. Hersch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Neurology Business Group
200 Metro Boulevard
Nutley, NJ 07110Phone+1 201-746-2023- Is this information wrong?
Summary
- Dr. Steven Hersch is a neurologist in Boston, MA and is affiliated with Massachusetts General Hospital, Harvard Medical School. He received his medical degree from Boston University School of Medicine and has been in practice 33 years. He specializes in neurodegenerative disorders and is experienced in memory disorders, movement disorders, and Huntington's disease and in clinical development of experimental therapeutics.
Education & Training
- Emory University School of MedicineResidency, Neurology, 1985 - 1990
- Boston University School of MedicineClass of 1984
Certifications & Licensure
- MA State Medical License 2001 - 2024
- NH State Medical License 2021 - 2023
- ME State Medical License 2021 - 2023
- RI State Medical License 2021 - 2022
- GA State Medical License 1987 - 2005
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Creatine Therapy for Huntington's Disease Start of enrollment: 2001 Oct 01
- Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) Start of enrollment: 2005 Aug 01
- Creatine Safety and Tolerability in Premanifest HD: PRECREST Start of enrollment: 2007 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsThe Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington's Disease.Hilda T Maibach, Michael J Brownstein, Steven M Hersch, Karen E Anderson, Debra E Itzkowitz, Eve M Damiano, Neal G Simon> ;Journal of Personalized Medicine. 2022 Sep 22
- Utility of the Huntington's Disease Prognostic Index Score for a Perimanifest Clinical Trial.Douglas R Langbehn, Elisabeth M Fine, Andreas Meier, Steven Hersch> ;Movement Disorders. 2022 May 1
- 1 citationsSuicidality Risk Factors Across the CARE-HD, 2CARE, and CREST-E Clinical Trials in Huntington Disease.Andrew McGarry, Peggy Auinger, Karl D Kieburtz, Amy-Lee Bredlau, Steven M Hersch, H Diana Rosas> ;Neurology. Clinical Practice. 2022 Apr 1
- Join now to see all
Journal Articles
- Complex Spatial and Temporally Defined Myelin and Axonal Degeneration in Huntington DiseaseS M Hersch, H D Rosas, ScienceDirect
Press Mentions
- Minnesota Farm Couple Raising Sheep to Help in Treating Human DiseaseJune 22nd, 2017
- Fearing Punishment for Bad GenesApril 7th, 2014
- Assay Shown to Be Effective in Measuring Levels of Mutant Huntingtin ProteinAugust 29th, 2013
- Join now to see all
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: